Form 4: BioCardia CEO Peter Altman Acquires 500 Shares of Common Stock
SEC Form 4 Filing
BioCardia's President and CEO, Peter Altman, purchased 500 shares of the company's common stock at an average price of $3.29 on June 21, 2024.
Summary
- On June 21, 2024, Peter Altman, the President and CEO of BioCardia, Inc., acquired 500 shares of common stock.
- The transaction was executed at a weighted average price of $3.29 per share, with individual trades ranging from $3.24 to $3.29.
- Following the reported transaction, Altman directly owns 39,245 shares of BioCardia's common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is a positive signal, but the transaction is relatively small and doesn't provide a strong indication of future performance.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued. However, it's just one factor among many to consider when evaluating a company's potential.
Stakeholder Impact
- The CEO's stock purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/21/2024 | Date of the transaction where Peter Altman acquired 500 shares of BioCardia's common stock. |
| 06/24/2024 | Date of signature for the Form 4 filing. |
Keywords
BioCardia, Peter Altman, BCDA, Insider Trading, Stock Acquisition, Form 4, SEC Filing, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.